Preventive effect of Lactobacillus fermentum Lee on activated carbon-induced constipation in mice

Qian,Yu; Suo,Huayi; Du,Muying; Zhao,Xin; Li,Jian; Li,Gui‑Jie; Song,Jia-Li; Liu,Zhenhu

doi:10.3892/etm.2014.2064

Preventive effect of Lactobacillus fermentum Lee on activated carbon-induced constipation in mice

Authors:
- Yu Qian
- Huayi Suo
- Muying Du
- Xin Zhao
- Jian Li
- Gui‑Jie Li
- Jia-Li Song
- Zhenhu Liu
View Affiliations

Affiliations: Department of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, P.R. China, College of Food Science, Southwest University, Chongqing 400715, P.R. China, Institute of Qinghai-Tibetan Plateau, Southwest University for Nationalities, Chengdu, Sichuan 610041, P.R. China, Department of Food Science and Nutrition, Pusan National University, Busan 609-735, Republic of Korea, Xinjiang Academy of Agricultural Sciences, Urumqi, Xinjiang 830091, P.R. China
Published online on: November 11, 2014 https://doi.org/10.3892/etm.2014.2064
Pages: 272-278

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the effects of Lactobacillus fermentum Lee (LF‑Lee) on activated carbon‑induced constipation in ICR mice. ICR mice were orally administered lactic acid bacteria for nine days. Body weight, dietary and water intake, defecation status, gastrointestinal (GI) transit and defecation time, as well as levels of motilin (MTL), gastrin (Gas), endothelin (ET), somatostatin (SS), acetylcholinesterase (AChE), substance P (SP) and vasoactive intestinal peptide (VIP) in serum were measured to evaluate the preventive effects of LF‑Lee on constipation. Bisacodyl, a laxative drug, was administered as a positive control. The time taken until the first defecation of a black stool for normal, control, bisacodyl‑ (100 mg/kg, oral administration), Lactobacillus bulgaricus (LB)-, LF‑Lee low dose (L)‑ and LF‑Lee high dose (H)‑treated mice was 90, 218, 117, 180, 161 and 151 min, respectively. Following the consumption of LB, LF‑Lee (L) or LF‑Lee (H), or the oral administration of bisacodyl, the GI transit was reduced to 55.2, 65.8, 73.1 and 94.6%, respectively, of the transit in normal mice. The serum levels of MTL, Gas, ET, AChE, SP and VIP were significantly increased and those of SS were reduced in the mice treated with LF‑Lee compared with those in the untreated control mice (P<0.05). These results demonstrate that lactic acid bacteria have preventive effects on constipation in mice and that LF‑Lee has superior functional activity.

View Figures

View References

1	Wu CS, Li J, Qian Y and Suo HY: Research progress of yak milk and fermented yak milk and their nutritional value. J Dairy Sci Technol. 35:43–46. 2012.(In Chinese).
2	Wu CS, Su C, Li J, Qian Y and Suo HY: The research progress and prospect of yak yogurt lactic acid bacteria. Food Ind. 33:129–133. 2012.(In Chinese).
3	Ueki A and Otsuka M: Life style risks of Parkinson’s disease: association between decreased water intake and constipation. J Neurol. 251(Suppl 7): vii18–vii23. 2004. View Article : Google Scholar
4	Wexner SD, Beck DE, et al: A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest Endosc. 63:894–909. 2006. View Article : Google Scholar : PubMed/NCBI
5	Farrugia G, Miller SM, Rich A, Liu X, Maines MD, Rae JL and Szurszewski JH: Distribution of heme oxygenase and effects of exogenous carbon monoxide in canine jejunum. Am J Physiol. 274:G350–G358. 1998.PubMed/NCBI
6	Farrugia G, Lei S, Lin X, Miller SM, et al: A major role for carbon monoxide as an endogenous hyperpolarizing factor in the gastrointestinal tract. Proc Natl Acad Sci USA. 100:8567–8570. 2003. View Article : Google Scholar : PubMed/NCBI
7	Miller SM, Reed D, Sarr MG, Farrugia G and Szurszewski JH: Haem oxygenase in enteric nervous system of human stomach and jejunum and co-localization with nitric oxide synthase. Neurogastroenterol Motil. 13:121–131. 2001. View Article : Google Scholar : PubMed/NCBI
8	Xue L, Farrugia G, Miller SM, Ferris CD, Snyder SH and Szurszewski JH: Carbon monoxide and nitric oxide as coneurotransmitters in the enteric nervous system: evidence from genomic deletion of biosynthetic enzymes. Proc Natl Acad Sci USA. 97:1851–1855. 2000. View Article : Google Scholar : PubMed/NCBI
9	Battish R, Cao GY, Lynn RB, Chakder S and Rattan S: Heme oxygenase-2 distribution in anorectum: colocalization with neuronal nitric oxide synthase. Am J Physiol Gastrointest Liver Physiol. 278:G148–G155. 2000.PubMed/NCBI
10	Xiong T, Song SH, Huang JQ, Huang Y and Xie MY: Tolerance of Lactobacillus plantarum NCU116 in stimulated digestive environments. Food Sci. 32:114–117. 2011.(In Chinese).
11	Zhao WJ, Lv JL, Ma Q and Li Y: Analysis of the surface hydrophobicity of Lactobacillus acidophilus. China Dairy Ind. 39:8–11. 2011.(In Chinese).
12	Qian Y, Zhao X and Kan J: Preventive effect of resistant starch on activated carbon-induced constipation in mice. Exp Ther Med. 6:228–232. 2013.PubMed/NCBI
13	Dolk A, Brodén G, Holmström B, Johansson C and Schultzberg M: Slow transit chronic constipation (Arbuthnot Lane’s disease). An immunohistochemical study of neuropeptide-containing nerves in resected specimens from the large bowel. Int J Colorectal Dis. 5:181–187. 1990. View Article : Google Scholar : PubMed/NCBI
14	Walia R, Mahajan L and Steffen R: Recent advances in chronic constipation. Curr Opin Pediatr. 21:661–666. 2009. View Article : Google Scholar : PubMed/NCBI
15	Emmanuel AV, Tack J, Quigley EM and Talley NJ: Pharmacological management of constipation. Neurogastroenterol Motil. 21(Suppl 2): 41–54. 2009. View Article : Google Scholar : PubMed/NCBI
16	Lubowski DZ, Chen FC, Kennedy ML and King DW: Results of colectomy for severe slow transit constipation. Dis Colon Rectum. 39:23–29. 1996. View Article : Google Scholar : PubMed/NCBI
17	Mercenier A, Pavan S and Pot B: Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des. 9:175–191. 2003. View Article : Google Scholar : PubMed/NCBI
18	Saarela M, Mogensen G, Fondén R, Mättö J and Mattila-Sandholm T: Probiotic bacteria: safety, functional and technological properties. J Biotechnol. 84:197–215. 2000. View Article : Google Scholar
19	Marteau P, Minekus M, Havenaar R and Huis in’t Veld JH: Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J Dairy Sci. 80:1031–1037. 1997. View Article : Google Scholar : PubMed/NCBI
20	Gibson GR and Roberfroid MB: Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 125:1401–1412. 1995.PubMed/NCBI
21	Salminen S and Salminen E: Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J Gastroenterol Suppl. 222:45–48. 1997.PubMed/NCBI
22	Sjölund K, Ekman R, Akre F and Lindner P: Motilin in chronic idiopathic constipation. Scand J Gastroenterol. 21:914–918. 1986. View Article : Google Scholar : PubMed/NCBI
23	el-Salhy M and Norrgård O: Colonic neuroendocrine peptide levels in patients with chronic idiopathic slow transit constipation. Ups J Med Sci. 103:223–230. 1998. View Article : Google Scholar
24	Silkoff P, Karmeli F, Goldin E, Ewenson A, Gilon C, Chorev M, et al: Effect of substance P on rat gastrointestinal transit. Digest Dis Sci. 33:74–77. 1988. View Article : Google Scholar : PubMed/NCBI
25	Feighner SD, Tan CP, McKee KK, Palyha OC, Hreniuk DL, Pong SS, et al: Receptor for motilin identified in the human gastrointestinal system. Science. 284:2184–2188. 1999. View Article : Google Scholar : PubMed/NCBI
26	Preston DM, Adrian TE, Christofides ND, Lennard-Jones JE and Bloom SR: Positive correlation between symptoms and circulating motilin, pancreatic polypeptide and gastrin concentrations in functional bowel disorders. Gut. 26:1059–1064. 1985. View Article : Google Scholar : PubMed/NCBI
27	Soudah HC, Hasler WL and Owyang C: Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 325:1461–1467. 1991. View Article : Google Scholar : PubMed/NCBI
28	Furchgott RF and Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:373–376. 1980. View Article : Google Scholar : PubMed/NCBI
29	Tzavella K, Riepl RL, Klauser AG, Voderholzer WA, Schindlbeck NE and Müller-Lissner SA: Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroen Hepatol. 8:1207–1211. 1996. View Article : Google Scholar
30	Milner P, Crowe R, Kamm MA, Lennard-Jones JE and Burnstock G: Vasoactive intestinal polypeptide levels in sigmoid colon in idiopathic constipation and diverticular disease. Gastroenterology. 99:666–675. 1990.PubMed/NCBI